Knowledge Center

Patent / Jan 01, 1966

Tetracycline process

Authors:
  • Ivan Villax
Source:
BE 658387

A newly isolated strain of Streptomyces lusitanus var tetracyclini NCIB 9500 produces tetracycline with no co-production of chlortetracycline in the presence of Cl-. Thus, in a 6000-1. fermentor, with corn-steep medium contg. 1.5 g. NH4Cl/l. the strain produces 11.1 g. tetracycline/l. and no detectable amt. of chlortetracycline.

Also in the Knowledge Center

Related Content

Exclusive partnerships

Hovione has experience of developing and supplying off-patent APIs on an exclusive basis.

Page
Read more

Drug Product Development

Leveraging our expertise particle engineering, Hovione can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

ASD-HIPROS

ASD-HIPROS, Hovione’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.

Page
Read more